Table 3.
Cox regression on Mortality risk of HIV/MTB co-infection in different stratification by TB treatment outcome
Stratification | TB Treatment outcome | β | SE | Wald | df | P value | Exp (β) | 1-Exp (β) (%) | 95.0% Exp(β) Confidential Interval | |
---|---|---|---|---|---|---|---|---|---|---|
lower limit | Upper limit | |||||||||
ART and ART naïve | Adverse events, failure, missing | 26.19 | 2.00 | < 0.0001 | ||||||
Complete treatment | −.548 | 0.12 | 20.00 | 1.00 | < 0.0001 | 0.58 | 42.18 | 0.45 | 0.74 | |
Cure | −.665 | 0.14 | 23.75 | 1.00 | < 0.0001 | 0.51 | 48.55 | 0.39 | 0.67 | |
Gender | Adverse events, failure, missing | 21.38 | 2.00 | < 0.0001 | ||||||
Complete treatment | −.521 | 0.12 | 18.16 | 1.00 | < 0.0001 | 0.59 | 40.63 | 0.47 | 0.75 | |
Cure | −.575 | 0.14 | 17.83 | 1.00 | < 0.0001 | 0.56 | 43.70 | 0.43 | 0.74 | |
Age group | Adverse events, failure, missing | 14.49 | 2.00 | 0.0007 | ||||||
Complete treatment | −.449 | 0.12 | 13.23 | 1.00 | 0.0003 | 0.64 | 36.17 | 0.50 | 0.81 | |
Cure | −.458 | 0.14 | 11.02 | 1.00 | 0.0009 | 0.63 | 36.75 | 0.48 | 0.83 | |
CD4 group | Adverse events, failure, missing | 17.87 | 2.00 | 0.0001 | ||||||
Complete treatment | −.486 | 0.13 | 14.35 | 1.00 | 0.0002 | 0.62 | 38.47 | 0.48 | 0.79 | |
Cure | −.567 | 0.14 | 16.07 | 1.00 | 0.0001 | 0.57 | 43.28 | 0.43 | 0.75 |